Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

TerminatedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Neuroblastoma
Interventions
DRUG

lorlatinib

Oral

Trial Locations (11)

1142

Starship Blood and Cancer Centre, Auckland

2145

Westmead Hospital, Westmead

19104

University of Pennsylvania School of Medicine, Philadelphia

41650

Queen Silvia Children's Hospital, Gothenburg

46370

Seoul National University Bundang Hospital, Seongnam

58185

HRH Crown Princess Victoria's Children and Youth Hospital, Linköping

Unknown

ST0683AU - Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050 Australia

Instituto Portugues de Oncologia de Lisboa, Lisbon

06351

Samsung Medical Center, Seoul

S-171 77

Karolinska Institutet, Stockholm

901 85

Norrland University Hospital, Umeå

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04753658 - Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib | Biotech Hunter | Biotech Hunter